These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137 [TBL] [Abstract][Full Text] [Related]
4. Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Lee MW; Yeon SH; Heo BY; Kwon J; Ryu H; Lee HJ; Yun HJ; Jo DY; Song IC Hematology; 2021 Dec; 26(1):96-102. PubMed ID: 33459581 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients. Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Shono Y; van den Brink MRM Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660 [TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
10. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364 [TBL] [Abstract][Full Text] [Related]
11. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease. Kumari R; Palaniyandi S; Hildebrandt GC Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482 [TBL] [Abstract][Full Text] [Related]
12. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates. Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074 [TBL] [Abstract][Full Text] [Related]
13. [GVHD: pathophysiology and novel agents]. Ara T; Hashimoto D Rinsho Ketsueki; 2022; 63(9):1261-1269. PubMed ID: 36198552 [TBL] [Abstract][Full Text] [Related]
14. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668 [TBL] [Abstract][Full Text] [Related]
15. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid. Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237 [TBL] [Abstract][Full Text] [Related]
16. Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease. Hueso T; Gauthier J; Joncquel Chevalier-Curt M; Magro L; Coiteux V; Dulery R; Carpentier B; Labreuche J; Damaj G; Yakoub-Agha I; Seguy D Clin Gastroenterol Hepatol; 2018 Jun; 16(6):908-917.e2. PubMed ID: 29258901 [TBL] [Abstract][Full Text] [Related]
17. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729 [TBL] [Abstract][Full Text] [Related]
18. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study. Bilinski J; Robak K; Peric Z; Marchel H; Karakulska-Prystupiuk E; Halaburda K; Rusicka P; Swoboda-Kopec E; Wroblewska M; Wiktor-Jedrzejczak W; Basak GW Biol Blood Marrow Transplant; 2016 Jun; 22(6):1087-1093. PubMed ID: 26900084 [TBL] [Abstract][Full Text] [Related]
19. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907 [TBL] [Abstract][Full Text] [Related]
20. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation. Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]